68Ga-PSMA PET/CT对mpMRI阴性临床显著病灶检出特异性提高:单中心根治性前列腺切除组织学对比分析
该单中心回顾性队列研究纳入58例术前行mpMRI和68Ga-PSMA PET/CT后接受根治性前列腺切除的患者,以全腺体组织病理为参考,比较两种影像的诊断准确性。68Ga-PSMA PET/CT对多灶和双侧病变的检出优于mpMRI,作者认为可能影响手术规划、靶向活检和局灶治疗策略,需进一步研究。
要点
- 58例高危队列(≥pT3占69%)中,68Ga-PSMA PET/CT检出更多癌灶(78%,AUC 0.817) vs mpMRI(69%,AUC 0.729)。
- 双侧病变灵敏度:68Ga-PSMA PET/CT 42% vs mpMRI 21%;多灶病变:34% vs 19%。
- 作者认为68Ga-PSMA PET/CT可能更好地反映根治性前列腺切除组织病理,需进一步研究。
核心结论
- 作者认为,在考虑多灶和双侧病变时,68Ga-PSMA PET/CT可能比mpMRI更好地反映根治性前列腺切除组织病理。
- 作者认为这些发现可能影响手术规划、靶向活检和局灶治疗策略,并需要进一步研究。
研究设计与样本
- 单中心回顾性队列研究,连续纳入术前接受mpMRI和68Ga-PSMA PET/CT后行根治性前列腺切除的患者。
- 共58例患者,中位年龄65.5岁,中位PSA 7.35 ng/mL,高危队列(≥pT3占69%)。
- 以根治性前列腺切除全腺体组织病理为参考,行基于患者的分析和基于病灶的分析,采用灵敏度、特异度及其他诊断准确性指标。
主要发现
- 识别指数病灶、双侧病变和多灶病变的灵敏度:mpMRI分别为90%、21%、19%,68Ga-PSMA PET/CT分别为93%、42%、34%。
- 组织学分析显示88个癌灶,Gleason分级3+3占4%、3+4占64%、4+3占19%、4+4占3%、≥4+5占10%。
- 68Ga-PSMA PET/CT正确检出更多癌灶(78%,AUC 0.817) vs mpMRI(69%,AUC 0.729)。
关键数值与推荐
- 识别指数病灶灵敏度:68Ga-PSMA PET/CT 93% vs mpMRI 90%。
- 识别双侧病变灵敏度:68Ga-PSMA PET/CT 42% vs mpMRI 21%。
- 识别多灶病变灵敏度:68Ga-PSMA PET/CT 34% vs mpMRI 19%。
- 基于病灶检出率:68Ga-PSMA PET/CT 78%(AUC 0.817) vs mpMRI 69%(AUC 0.729)。
临床怎么用
- 作者认为68Ga-PSMA PET/CT可能更好地反映根治性前列腺切除组织病理,尤其考虑多灶和双侧病变时。
- 作者认为这些发现可能影响手术规划、靶向活检和局灶治疗策略。
局限性
- 原文在结论中写明需要进一步研究。
- 原文未报告其他局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: Positron emission tomography (PET) for prostate-specific membrane antigen (PSMA) represents a promising method for prostate cancer diagnosis and staging. Comparisons of PSMA-based tumour characterisation to multiparametric MRI (mpMRI) are limited, hence this study sought to compare the diagnostic accuracy of 68Ga-PSMA PET/CT to mpMRI against radical prostatectomy (RP) whole gland histopathology. METHODS: A retrospective cohort study of consecutive patients who underwent pre-operative mpMRI and 68Ga-PSMA PET/CT followed by a RP was performed. Standard clinical parameters were collected. "Per patient" and "per lesion" analyses for image-based detection according to RP histopathology were described using sensitivity, specificity and other measures of diagnostic accuracy. RESULTS: Fifty-eight patients (median age 65.5 years, median PSA 7.35 ng/mL) underwent RP, resulting in a high-risk cohort (≥pT3 69%). Sensitivities for identification of index lesion, bilateral and multifocal disease were 90%, 21%, 19% for mpMRI and 93%, 42%, 34% for 68Ga-PSMA PET/CT. Histology analyses revealed 88 cancer foci of Gleason grades 3 + 3 (4%), 3 + 4 (64%), 4 + 3 (19%), 4 + 4 (3%) and ≥ 4 + 5 (10%), of which 68Ga-PSMA PET/CT correctly detected more foci (78%, AUC 0.817) than mpMRI (69%, AUC 0.729). CONCLUSIONS: 68Ga-PSMA PET/CT may better reflect RP histopathology compared to mpMRI when considering multifocal and bilateral disease. These findings may influence surgical planning, targeted biopsy and focal therapy strategies and require further research.
引用
- Donato P, Roberts MJ, Morton A, et al. Improved specificity with 68Ga PSMA PET/CT to detect clinically significant lesions "invisible" on multiparametric MRI of the prostate: a single institution comparative analysis with radical prostatectomy histology. Eur J Nucl Med Mol Imaging. 2018. PMID: 30229528. doi:10.1007/s00259-018-4160-7
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。